Skip to main content
. Author manuscript; available in PMC: 2020 Apr 21.
Published in final edited form as: Interdiscip Sci. 2019 May 20;11(2):273–281. doi: 10.1007/s12539-019-00335-w

Table 2.

Frequencies and ORs of CHOLESTASIS information if three drugs were used in different combinations in ALL group.

Drug combination NC+all Nall FreqC/all OR lnOR Error NP NC+P FreqC/P
AMXC+OMPZ+LSPZ 31 445 6.97% 40.59 3.70 0.37 23 23 100.00%
AMXC+OMPZ-LSPZ 170 6793 2.50% 14.02 2.64 0.15 21 2 9.52%
AMXC+LSPZ-OMPZ 31 2864 1.08% 5.93 1.78 0.35 5 0 0.00%
  LSPZ+OMPZ-AMXC 27 4731 0.57% 3.11 1.13 0.38 6 0 0.00%
AMXC-LSPZ-OMPZ 1279 56346 2.27% 13.49 2.60 0.06 542 4 0.74%
OMPZ-LSPZ-AMXC 974 250340 0.39% 2.18 0.78 0.06 574 3 0.52%
LSPZ-OMPZ-AMXC 342 94558 0.36% 1.98 0.69 0.11 158 1 0.63%

NC+all, Number of records with CHOLESTASIS and the drug combination in the “ALL” group; Nall, Number of records containing the drug combination in the “ALL” group; FreqC/all, Frequency of CHOLESTASIS after taking the drug combination in the “ALL” group; NP, Number of drug combination in the “pregnancy” group; NC+P, Number of records with CHOLESTASIS and the drug combination in the “pregnancy” group; FreqC/P, Frequency of CHOLESTASIS after taking the drug combination in the “pregnancy” group.